Effect of Atazanavir on Endothelial Function in HIV-Infected Patients Compared to Standard Proteinase Inhibitors on Top of Potent Antiviral Combination Therapy.

Trial Profile

Effect of Atazanavir on Endothelial Function in HIV-Infected Patients Compared to Standard Proteinase Inhibitors on Top of Potent Antiviral Combination Therapy.

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Jun 2009

At a glance

  • Drugs Antiretrovirals; Atazanavir; HIV protease inhibitors
  • Indications HIV infections
  • Focus Adverse reactions
  • Acronyms ENDOPACT
  • Most Recent Events

    • 06 Jun 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top